Latest Finasteride Stories
Finasteride, a popular treatment for male pattern baldness also known as Propecia, can reduce a person’s risk of contracting prostate cancer by about one-third, according to research appearing in the August 15 issue of the New England Journal of Medicine.
A long-term follow-up to a groundbreaking study led by the director of the Cancer Therapy & Research Center confirms that a drug shown to reduce risk of prostate cancer by more than a third has no impact on lifespan but further reduces the risk of prostate cancer.
Court data updated on July 10, indicate that there are 183 actions pending in the Propecia Multidistrict Litigation.
According to court data updated on May 14, there are 181 actions currently pending in the Propecia Multidistrict Litigation.
Renowned hair loss expert and national product consultant Dr. Alan Bauman unveils a new therapeutic shampoo line for patients with thinning hair.
Finasteride is a synthetic drug for the treatment of male pattern hair loss (MPHL) and an enlarged prostate.
Advanced Male Medical Center's 20 percent testosterone cream helps men suffering from testicular hypogonadism. San Francisco, CA (PRWEB) May 29, 2013
d’Oliveira & Associates wants to inform the public on the continuing risks associates with the Merck Drug and that they now offer a new “No Win No Fee Promise” for those with a Propecia
On March 28, 2013 B.C. Judge approved a class action lawsuit filed by a man alleging sexual dysfunction from Propecia.
- totally perplexed and mixed up.